Fig. 10. Preparation of (a) PLL–ICG/DPEG and (b) PLL–ICG/SPEG NPs using the MS templating method for PTT and PDT. (c) Cell viability in the presence of ICG, PLL–ICG/DPEG NPs, and PLL–ICG/SPEG NPs with NIR laser irradiation. (d) Comparison of PDT, PTT, and simultaneous PDT/PTT effects on cell viability. Reproduced with permission from ref. 115. Copyright 2019, American Chemical Society. (e) Schematic illustration of the DOX&ICG@MSN-T@poly A design, triggered drug release, anticancer process, and immunity activation mechanism. Reproduced with permission from ref. 116. Copyright 2019, American Chemical Society.
